Type 1 reaction in leprosy: a model for a better understanding of tissue immunity under an immunopathological...

Area of Science:

• Immunology
• Dermatology
• Infectious Diseases

Background:

• Type 1 reaction (T1R), also known as reversal reaction, is a primary cause of leprosy-related disabilities and deformities.
• Leprosy patients may experience T1R episodes long after completing treatment, posing diagnostic and management challenges.
• Current treatment with corticosteroids for T1R is associated with frequent iatrogenic complications.

Purpose of the Study:

• To review the persistent challenges in managing Type 1 Reaction (T1R) in leprosy.
• To identify key issues in T1R management, bridging basic research and clinical practice.
• To highlight the need for improved diagnostic tools and biomarkers for T1R.

Main Methods:

• Literature review of current research on Type 1 Reaction (T1R) in leprosy.
• Analysis of diagnostic challenges and treatment strategies for T1R.
• Discussion of potential biomarkers for predicting and differentiating T1R.

Main Results:

• Early diagnosis of T1R remains a significant hurdle in effective leprosy management.
• Biomarkers are urgently needed to predict recurrent T1R and distinguish it from relapse.
• Corticosteroid treatment for T1R frequently leads to iatrogenic complications.

Conclusions:

• There is a critical need for improved strategies for early T1R diagnosis and management.
• Developing reliable biomarkers is essential to prevent recurrent T1R and differentiate it from relapse.
• Reducing the gap between basic research and clinical application is vital for better T1R outcomes.